Recently, the PAT family of proton-dependent amino acid transporters has been identified as a novel class of mammalian amino acid symporters. PAT1 and PAT2 members mediate electrogenic uptake of small, neutral amino acids and derivatives by cotransport of protons. Analysis of the structural requirements for substrate recognition by PAT1 identified that a free amino group in a substrate is not essential for recognition. We therefore hypothesized that PAT1 and its ortholog PAT2 may also be able to recognize and transport the homologous short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. We examined in Xenopus laevis oocytes whether the SCFAs interact with the transporter by employing flux studies, electrophysiology and intracellular pH recordings. SCFAs did not induce positive inward currents but inhibited glycine-induced transport currents. PAT-mediated uptake of radiolabeled proline was also dose-dependently reduced by SCFA and could be described by first order competition kinetics with apparent K i -values for butyrate of 6.0 ± 0.7 and 7.6 ± 1.3 mM for PAT1 and PAT2, respectively. Acetate as well as propionate uptake was significantly enhanced in oocytes expressing PAT1 or PAT2. An electroneutral H + /SCFA symport mode was demonstrated by recording intracellular pH changes under voltage clamp conditions with rate constants for the initial intracellular acidification in the presence of SCFAs significantly increased in PAT-expressing oocytes. In conclusion, our data demonstrate that the PAT1 and PAT2 proteins are capable to transport selected SCFAs in an electroneutral and the homologous amino acids in an electrogenic mode and are therefore a paradigm for bifunctional solute carriers.
described in apical plasma membranes of mammalian epithelial cells (6) (7) (8) (9) (10) and in the human intestinal cell line Caco-2 (11) (12) (13) (14) , the molecular structure of the underlying protein entities was not known.
By means of homology based cloning, a family of proton-dependent amino acid transporters, designated as PAT1 and LYAAT (proton/amino acid transporter; lysosomal amino acid transporter), was identified and characterized at the molecular level (15) (16) (17) (18) . The PAT family comprises four members, PAT1 to PAT4, of which only the first two members, PAT1/LYAAT-1 and PAT2, have been shown experimentally to mediate proton-coupled symport of amino acids with a high selectivity for amino acids with small and apolar side chains (19) . PAT1 was shown to transport glycine, L-alanine, and L-proline as well as D-serine and the neurotransmitter γ-aminobutyrate (GABA) (15, (17) (18) (19) (20) , whereas PAT2 recognizes in addition to small L-α-amino acids also D-proline (15, 16, 21) . Both transporters possess a 1:1 flux coupling stoichiometry for proline transport. Substrate affinities range from around 2.8 to 7.5 mM (PAT1) and 0.1 to 0.7 mM (PAT2) for the same substrates (15, 22) . The cloning of the human PAT1-cDNA from the Caco-2 cell line and the immunolocalization of the PAT1-protein in the apical membrane of Caco-2 cells proved that PAT1 represents the molecular entity of the described previously PAT system (17) . The murine isoform PAT1 is expressed in a variety of tissues and shows highest expression levels in small intestine, kidney and in both proximal and distal colon (15, 17) . PAT1 is also strongly expressed in brain and was found there in lysosomes and the plasma membrane of neurons in several regions of the brain (18, 22, 23) . The expression pattern of PAT2 differs from that of PAT1. High expression levels are found in lung and heart; weaker signals are detected in kidney, testis, and muscle (15) . Immunodetection studies revealed that PAT2 is expressed in spinal cord and brain where it is abundantly found in neuronal cell bodies of Nmethyl-D-aspartate receptor subunit NR1 positive neurons (21) . Subcellular localization studies revealed that the PAT2 protein is targeted to the plasma membrane of X. laevis oocytes, and with the use of brain slices, it has been demonstrated that endogenous PAT2 localizes, at least in part, to the plasma membrane of neurons (21) .
We have recently analyzed the structural requirements in substrates in terms of variability of the side chain, backbone length and the role of the terminal head groups for interaction with the cloned murine PAT1-protein (20) . A remarkable characteristic of PAT1 is the discrimination of substrates by the size of the side chain and by the charge separation distance within the backbone. In L-amino acids, a maximum of one CH 2 -unit in the side chain is accepted. Beside L-α-amino acids, PAT1 also tolerates ϖ-amino acids with a maximal distance of two CH 2 -units between amino and carboxy group, represented by GABA as a high-affinity substrate of PAT1. Methylation of the carboxy group reduces transport capability whereas a methylation of the amino group has only a minor effect on affinity and transport capacity (20) . This mainly applies also to PAT2. Therefore, a free amino group in a substrate is not essential for substrate recognition by PAT1 and PAT2. We consequently asked whether PAT1 and/or PAT2 are able to recognize also short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate as substrates. SCFAs are abundant organic anions and serve as energy substrates and particularly the colonic mucosa utilizes them (24, 25) . Moreover, butyrate is an important modulator of gene expression and cell cycle control (26) (27) (28) (29) . We examined the interaction of SCFAs with the PAT1 and PAT2 proteins using flux studies, electrophysiology, and intracellular pH measurements in X. laevis oocytes expressing either PAT1 or PAT2 and demonstrate a novel bifunctional transport mode for these two symporters.
METHODS

Materials
Female X. laevis frogs were purchased from Nasco (Fort Atkinson, WI 
Amino acid and SCFA uptake experiments
X. laevis oocytes handling and cRNA injection have been described previously (15) . Oocytes were injected with 10 nl sterile water (control), 10 nl murine PAT1-cRNA (5 ng), 10 nl murine PAT2-cRNA (20 ng), and 10 nl rabbit PEPT1-cRNA (15 ng), respectively. The oocytes were kept in modified Barth solution (88 mM NaCl, 1 mM KCl, 0.8 mM MgSO 4 , 0.4 mM CaCl 2 , 0.3 mM Ca(NO 3 ) 2 , 2.4 mM NaHCO 3 , and 10 mM HEPES, pH 7.5) at 18°C until further use (3-5 days after injection).
Ten oocytes (water-or cRNA-injected) per uptake experiment were preincubated at room temperature for 2 min in standard uptake buffer solution (100 mM sodium chloride, 2 propionate as a tracer (10 µCi/ml). After 5 min (acetate and propionate uptake), or 10 min incubation (amino acid uptake) the oocytes were washed three times with 3 ml of ice cold wash buffer solution (standard uptake buffer solution) and distributed to individual vials. After oocyte lysis in 10% SDS, radioactivity was counted by liquid scintillation. Kinetics of inhibition of amino acid uptake by SCFAs were constructed from experiments employing six different inhibitor concentrations in standard uptake buffer solution at pH 5.5 with 10 oocytes expressing mPAT1 or mPAT2 from at least two different oocyte batches. The osmolarity in all buffer solutions was adjusted by replacement of mannitol. PAT-specific uptake rates were obtained after subtraction of baseline uptake rates in water-injected control oocytes.
Two electrode voltage clamp experiments
Two-electrode voltage clamp experiments were performed as described previously (30) . Oocytes were placed in an open chamber, voltage clamped at -40 mV, and continuously superfused with standard perfusion buffer (100 mM sodium chloride, 2 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM MES, or HEPES at pH 5.5) in the absence or presence of amino acids. Current traces were recorded during voltage clamping and substrates were perfused at concentrations of 20 mM for 20 s. Kinetics of inhibition of amino acid induced currents by SCFAs were constructed from experiments employing seven different concentrations in sodium-containing buffer solution at pH 5.5 with eight individual oocytes expressing PAT1 from at least two different oocyte batches. The osmolarity in all buffer solutions was adjusted by replacement of mannitol.
Intracellular pH recordings in X. laevis oocytes
Intracellular pH recordings were performed as described previously (20) . We only used pH microelectrodes with slopes of 57-59 mV/pH unit and a very rapid response time. Initial acidification rates in response to perfusion with different substrates were determined in the same oocyte. Acidification was always linear in a time range of 10-30 s after substrate application and the slope of the initial acidification was calculated by linear regression of the data obtained in this time range. To exclude variations in acidification rates by different functional expression levels of the PAT1 transporter in different oocytes, a complete set of substrates (acetate, propionate, butyrate and glycine) was always measured in the same oocyte and only those oocytes were chosen that showed similar glycine induced charge movements.
Calculations and statistics
All data are means ± SE of at least two independent experiments with n = 8-10 oocytes per data point. Significant differences in data were calculated using paired or unpaired two-tailed Student's t test or ANOVA (using the Bonferroni multiple comparisons post-test). Apparent K ivalues were determined from IC 50 values based on competition curves and by the least-squares method. All calculations were performed using Prism software (GraphPad, San Diego, CA).
RESULTS
Interaction of SCFAs with the substrate binding side of the proton/amino acid cotransporters PAT1 and PAT2
Glycine, a prototype substrate of PAT1 evoked high inward currents in PAT1 expressing oocytes, whereas neither the monoamine propylamine nor the monocarboxylate propionate caused any inward currents at concentrations as high as 20 mM and at a pH of 5.5 (Fig. 1A) . Similar data were obtained in oocytes expressing PAT2 (not shown). Whereas transport currents of 0.5 mM glycine also remained unaffected by coperfusion with 10 mM propylamine, 10 mM propionate reduced glycine currents to 35.0 ± 4.7% of control values ( Fig. 1B and C) . Similar to propionate, neither acetate nor butyrate alone did induce any measurable currents by PAT1 ( Fig.  2A) or PAT2 (Fig. 2B ). However, all three SCFAs reduced glycine currents by PAT1 when provided in an 20-fold excess to 56.5 ± 8.6% (acetate), 32.9 ± 1.6 (propionate) or 21.2 ± 1.9% (butyrate) as shown in Fig. 2C . Fatty acid induced inhibition on glycine currents was also observed in the presence of pentanoate and hexanoate with 35.5 ± 2.0%and 41.3 ± 5.2% of residual glycine currents, respectively. However, a further increase in the carbon chain length to octanoic acid resulted in a weak inhibition (81.2±6.1%). When the PAT2 protein was expressed in X. laevis oocytes, glycine (1 mM) elicited currents of 411 nA ± 30 nA and those were reduced by 20 mM acetate to 23.1 ± 1.6% and by propionate to 26.7 ± 4.0% of control values, respectively. In contrast to those SCFA, neither lactate nor pyruvate reduced glycine currents; they even increased slightly to 120.7 ± 7.5 and 114.7 ± 4.6% of control values (Fig. 2C ). This finding strongly suggests that the introduction of a polar residue into the aliphatic chain in SCFA prevents any interaction of the fatty acids with the transporters binding site whereas fatty acids with a carbon chain length up to six carbons are effective competitors.
Since the SCFA by pH-partition and nonionic diffusion of the nonionized species could cause a decline in intracellular pH and in turn by reducing transmembrane ∆pH reduce the driving force for proton-dependent glycine symport, we assessed whether the SCFA also modify transport of the di-and tripeptide transporter PEPT1 protein that is also an electrogenic proton-dependent symporter with similar transport characteristics. As shown in Fig. 2D , PEPT1-mediated dipeptide currents at 1 mM substrate concentration were not affected significantly (P>0.05) by the addition of 20 mM propionate with 87.8 ± 11.9% (n=6) of current remaining when compared with the control.
Inhibition studies with the tracer L-[
3 H]proline confirmed the inhibitory effect of SCFAs on amino acid transport of PAT1 and PAT2. Acetate, propionate, butyrate, pentanoate and hexanoate at concentrations of 20 mM, decreased PAT1 mediated uptake of radiolabeled proline to 48 ± 6, 47 ± 9, 33 ± 7, 33.1 ± 5, and 48 ± 8% of control values, respectively. Octanoate perfusion resulted in a weaker, but still significant (P<0.05), decrease in proline uptake to 69 ± 8% of that in controls. In contrast, lactate and pyruvate did not influence uptake of L-proline (Fig. 3A) . PAT2-mediated L-proline influx was similarly reduced by acetate, propionate, and butyrate to 37.8 ± 2.7, 40.0 ± 4.5, and 26.0 ± 2.5% of control uptake (Fig. 3B) . To demonstrate that the SCFAs inhibit in a concentration dependent manner, we determined the kinetics of L-[ 3 H]proline uptake (100 µM) in the absence and the presence of increasing SCFA concentrations (0-50 mM) at pH 5.5. Inhibition by all three SCFAs followed typical first order competition kinetics. Proline uptake by PAT1 was inhibited by acetate, propionate and butyrate with apparent K i -values of 7.9 ± 0.5, 12.0 ± 1.6, and 5.6 ± 0.7 mM, respectively (Fig. 4A ). For PAT2, butyrate exhibited a K i -value of 7.6 ± 1.3 mM. Moreover, PAT1-mediated glycine currents also displayed a similar dose-dependent inhibition by propionate (Fig. 4B, inset ) under voltage clamp conditions with an apparent K i -value of 9.6 ± 0.9 mM (Fig. 4B ). This apparent affinity is similar to that obtained in the tracer flux studies with proline. Taken together, these findings establish that SCFA such as acetate, butyrate, and propionate do specifically and in a concentration dependent manner interact with the substrate binding site of PAT1 and PAT2 without generating any inward currents themselves.
Transport properties of radiolabeled SCFAs
To investigate whether the PAT-proteins do mediate SCFA transport into oocytes, uptake of 100 µM [ 3 H]acetate as well as [ 14 C]propionate was determined. Control oocytes possessed a very low intrinsic proline uptake capacity, but acetate and propionate were taken up at pH 5.5 at very high rates. Nevertheless, expression of PAT1 increased acetate and propionate influx to 131 ± 7 (Fig.  5A ) and 127 ± 3% (Fig. 5B) of control, respectively. When the PAT2 protein was expressed in the oocytes acetate uptake was increased 2.3 fold (Fig. 5A) and propionate uptake 1.5 fold (Fig.  5B) . In presence of 20 mM D-proline, PAT-specific acetate influx was almost completely inhibited to control values of 148.7 ± 6.1 and 176.1 ± 12.4 pmol/oocyte/5 min for PAT1 and PAT2, respectively (Fig. 5A ). For PAT1 this value was not significantly (P>0.05) different from that in control oocytes (144.8±5.1 pmol/oocyte/5 min).
Analysis of PAT1-mediated SCFA transport by combined voltage clamp and pH in measurements
Although PAT1 and PAT2 appear to transport acetate and propionate, TEVC studies show that this process is not electrogenic. The most plausible explanation would be a proton to substrate stoichiometry of 1:1 for the ionized species of the SCFA. To prove this assumption, we measured the corresponding changes in intracellular pH during SCFA transport under voltage clamp conditions. In response to acetate, propionate, and butyrate transport of SCFA by either PAT1 or PAT2 should cause a decline in pH in larger than in water injected control oocytes in which acidification occurs either by nonionic diffusion or via an endogenous transporter. Figure  6A shows the changes in intracellular pH in comparison to current responses. SCFA did never cause an inward current but reduced significantly pH in , whereas glycine induced a strong inward current in PAT1-expressing oocytes with a concomitant reduction in pH (Fig. 6A) . Perfusion with SCFA caused always a higher intracellular acidification in oocytes expressing PAT1 than in control oocytes. Figure 6B and Table 1 show the initial acidification rates induced by SCFA or by glycine in oocytes expressing PAT1 in comparison to control oocytes. The slopes of the PAT1-mediated decline in pH in in response to SCFA perfusion were 2.5 times (propionate) and 2.8 times (butyrate) higher than those obtained in control oocytes. As expected, a glycineinduced decrease of intracellular pH was only observed in oocytes expressing PAT1 with an acidification rate of -0.013 ± 0.002 ∆pH/sec; thus, it was very similar to that induced by butyrate. Furthermore, glycine induced charge movements (always measured as a control at the end of each experiment) correlated significantly with the acidification rates as measured for propionate, butyrate and glycine with r 2 values of 0.869, 0.888, and 0.862, respectively. Figure 6C demonstrates that an increase in PAT1-mediated glycine transport activity resulted always in a concomitant increase in acidification rates for all of the tested SCFAs.
DISCUSSION
The presence of proton/amino acid cotransport systems in the apical membranes of epithelial cells of rabbit renal tubules (6-10) or confluent monolayers of the epithelial cell line Caco-2 (12-14, 31) was shown functionally. Postcloning analysis of PAT1 suggests that this protein could be the responsible transporter for proton-dependent amino acid uptake in intestinal and renal cells. When expressed in X. laevis oocytes, PAT1 but also PAT2 mediate electrogenic proton-amino acid symport (15, 20) for small neutral amino acids. A further analysis of substrate recognition established that a free amino group is not an essential requirement for binding (20) and therefore we analyzed whether the PAT-transporters are able to transport the homologous SCFAs.
By electrophysiological analysis and uptake inhibition experiments with glycine and proline as substrates, we demonstrate that acetate, butyrate, and propionate are competing substrates for uptake by PAT1 and PAT2. Also pentanoate and hexanoate were found to inhibit PAT1 transport, whereas a further increase in chain length, as in octanoic acid reduced inhibition. Whether these medium chain fatty acids do serve as substrates is not known. However, this observation confirms our recent finding that δ-amino-pentanoic acid is transported electrogenically via PAT1, whereas a further elongation of the amino acid backbone abolishes the interaction with the PAT1 transporter (20) . We assume that the inhibition of PAT1-mediated amino acid transport by medium chain fatty acids results from their unrestricted conformation that allows them to be accommodated within the substrate binding pocket easily. In contrast, lactate and pyruvate do not interfere with the substrate binding site of the PAT-carriers showing that only unsubstituted monocarboxylic acids are recognized. This is in accordance with the previous observation that amino acids with polar side chains are only recognized by PAT1 (20) with very low affinity. Using radiolabeled acetate and propionate, we show that expression of PAT1 and PAT2 in oocytes increases SCFA uptake and that this influx is inhibited by amino acids. However, electrophysiology failed to demonstrate any associated transport currents when SCFA are provided as substrates. Recordings of intracellular pH changes established that SCFA uptake is associated with proton influx under voltage clamp conditions which strongly suggests that SCFA-influx occurs by proton symport most likely by transport of the SCFA-anion with a proton by a 1:1 flux coupling stoichiometry as shown also for proline (15, 22) . Initial rates of intracellular acidification by PAT1 caused by either butyrate or glycine uptake were similar whereas in case of propionate, acidification was twofold higher than with glycine. Similarly, acetate induced also twofold higher acidification rates (data not shown) than glycine. This suggests that the maximal transport rates by which PAT1 mediates propionate and acetate uptake are different from those obtained for glycine. Different maximal transport rates have also been observed for PAT1 with glycine and betaine despite very similar substrate affinities (20) . The higher initial acidification rates in case of propionate and acetate are mirrored by higher uptake rates of the corresponding radiolabeled substrates. Whereas proline uptake reached ~5 pmol/oocyte/min, acetate and propionate uptake rates reached around 10 pmol/oocyte/min, within the linear phase.
Acetate, propionate, and butyrate showed concentration dependent inhibition and exhibited apparent K i -values (5.6-12.0 mM) for PAT1 in the same range as the apparent K m (1-10 mM) values determined for its amino acid substrates (15, 20) . In comparison, PAT2 displays affinities in the range of 100-700 µM for the amino acid substrates (glycine, alanine, proline) but butyrate displayed an affinity almost 13-fold lower than that of glycine. This is in conformity with the observation that PAT2 is more restrictive with regard to the structural requirements in substrates for high affinity recognition than is PAT1 (15) .
Transmembrane transport of SCFAs is assumed to occur by different processes including nonionic diffusion, SCFA/anion-exchange and SCFA/proton symport. Permeation of the nonionized species of a SCFA occurs rapidly by the apolar character followed by fast intracellular dissociation (32, 33) . Driving forces for this process are the transmembrane concentration gradient of the SCFA and the transmembrane pH-gradient. Although transmembrane SCFA-movement after pH partition is a general phenomenon, the quantitative importance of this process in comparison to carrier-mediated SCFA-uptake mechanisms is discussed controversial.
In particular in colonic tissues, various studies have assessed the transport mode for SCFA that are produced in huge quantities by bacterial fermentation and it is believed that SCFA transport here occurs via an anion/SCFA exchange mechanism. SCFA uptake into isolated proximal colonic membrane vesicles was increased in the presence of outwardly directed bicarbonate, butyrate, or propionate gradients (34) (35) (36) (37) and Ussing chamber experiments also revealed that SCFAs are transported into the tissue via a bicarbonate/SCFA exchange mechanism (38) . Besides anion exchange processes, also a proton/SCFA symport mechanism was proposed.
Studies in the intestinal epithelial cell line Caco-2 (39) and in isolated epithelial cells from rabbit proximal colon (40) provided evidence for such a proton/SCFA cotransport system.
Until recently, only two transporter proteins mediating uptake of SCFAs have been characterized at the molecular level, the monocarboxylate cotransporter MCT1 (SLC16A1) (41) , and the newly identified sodium-coupled monocarboxylate transporter SMCT (SLC5A8) (42) . MCT1 has been demonstrated to catalyze the proton-coupled transport of monocarboxylates such as lactate, pyruvate, acetate, propionate, and butyrate and ketone bodies (41) . MCT1 is expressed in almost all tissues, inter alia in cecum, colon, and in kidney cortex (43) . Whether MCT1 is localized in the apical or basolateral membrane of epithelial cells is still not clear (44) , but it appears mainly to represent the basolateral form of the MCT series. The recently cloned SMCT transporters in contrast mediates Na + -coupled SCFA uptake and is expressed at high levels in colonic tissue. It transports lactate, pyruvate, acetate, butyrate, and propionate by an electrogenic Na + :SCFA cotransport mechanism (42).
With the data described here for PAT-mediated transport of the acetate, propionate, and butyrate, we add two new protein entities to the list of membrane carriers that can transport selected SCFA. The PAT1-mRNA is abundantly expressed with almost the same intensity along the gastrointestinal tract between stomach and descending colon, except in cecum (15, 17) . Additionally, the PAT1-protein was recently shown to localize to the apical membrane of cells of the human colon cancer cell line Caco-2 (17) . Besides ingestion of SCFA with the diet, acetate, propionate and butyrate are produced by microbial fermentation of nondigestible carbohydrates in colon and are present in the lumen in concentrations of 70-120 mM (45) . Whether PAT1 in the intestinal tissues contributes to overall SCFA uptake into the organism is currently not known. SCFAs are metabolized by colonic epithelial cells as a prime energy source but portal blood of different species has concentrations of SCFAs in the range from 0.4 mM and 5.3 mM (45, 46) and SCFAs delivered to circulation serve also as metabolic fuel of the liver and other peripheral tissues (45, 47) . PAT1-and also PAT2-mRNA expression is also fairly strong in liver, testis, muscle, brain, and heart (19), but their cellular and/or subcellular localization in these tissues is not known. Therefore, it appears to early to hypothesize that the PAT proteins do play a role in transport of SCFAs or that SCFA modulate PAT-mediated amino acid transport in these tissues and cell types.
In summary, we demonstrate that the mammalian PAT-proteins 1 and 2 are novel bifunctional proton-coupled symporters that operate in an electrogenic mode with amino acid substrates such as glycine, alanine, proline or GABA or in an electroneutral mode when the substrates lack an amino group. The demonstration of PAT-mediated proton/SCFA symport addresses a putative new function of these transporters in mammalian biology.
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